Subepithelial injection of botulinum toxin A for neurogecic detrusor overactivity (NDO) due to spinal cord injury
- Conditions
- eurogenic detrusor overactivity
- Registration Number
- JPRN-UMIN000001421
- Lead Sponsor
- ational Center for Geriatrics & Gerontology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 26
Not provided
1) The patient underwent the surgery such as bladder augmentation. 2) The patient underwent the treamtment using botulinum toxin A. 3) The patient underwent the surgery of lower urinary tract within 1 year. 4) The patient had symptomatic urinary tract infection, malignancy and bladder stone. 5) The patient is pregnant or breast-feed, or have possibility of such matter within 1 year. 6) The patient is diagnosed as having myasthenia gravis, Lambert-Eaton syndrome, amyotrophic lateral sclerosis. 7) The patient has disturbance of swallowing and/or respiration. 8) The patient has mental and/or cognitive disturbance to conduct clinical trial. 9) The patient is judged as being unsuitable for the trial by the researcher.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change of the number of urge/reflex urinary incontinence 1month after treatment
- Secondary Outcome Measures
Name Time Method Recurrence of urge/reflex urinary incontinence, change of bladder capacity after treatment